Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rydzewski

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
NPJ Genomic Medicine|October 17, 2022
Identification of phenocopies improves prediction of targeted therapy response over DNA mutations aloneHamza Bakhtiar, Kyle T Helzer, Yeonhee Park, et al.
Annals of Surgical Oncology|May 13, 2016
National Evaluation of the New Commission on Cancer Quality Measure for Postmastectomy Radiation Treatment for Breast CancerChristina A Minami, Karl Y Bilimoria, Nora M Hansen, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapyAishwarya Subramanian, Meng Zhang, Marina Sharifi, et al.
Practical Radiation Oncology|July 13, 2023
A Phase 1 Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate CancerKrishnan R Patel, Nicholas R Rydzewski, Erica Schott, et al.
NPJ Genomic Medicine|September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT SignaturesNicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.
Communications Biology|March 14, 2024
A platform-independent AI tumor lineage and site (ATLAS) classifierNicholas R Rydzewski, Yue Shi, Chenxuan Li, et al.
JAMA Oncology|September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate CancerRahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Molecular Oncology|February 22, 2025
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancerMarina N Sharifi, Eric Feng, Nicholas R Rydzewski, et al.
Nature Genetics|July 17, 2024
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancerShuang G Zhao, Matthew Bootsma, Stanley Zhou, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
NPJ Genomic Medicine|October 17, 2022
Identification of phenocopies improves prediction of targeted therapy response over DNA mutations aloneHamza Bakhtiar, Kyle T Helzer, Yeonhee Park, et al.
Annals of Surgical Oncology|May 13, 2016
National Evaluation of the New Commission on Cancer Quality Measure for Postmastectomy Radiation Treatment for Breast CancerChristina A Minami, Karl Y Bilimoria, Nora M Hansen, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapyAishwarya Subramanian, Meng Zhang, Marina Sharifi, et al.
Practical Radiation Oncology|July 13, 2023
A Phase 1 Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate CancerKrishnan R Patel, Nicholas R Rydzewski, Erica Schott, et al.
NPJ Genomic Medicine|September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT SignaturesNicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.
Communications Biology|March 14, 2024
A platform-independent AI tumor lineage and site (ATLAS) classifierNicholas R Rydzewski, Yue Shi, Chenxuan Li, et al.
JAMA Oncology|September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate CancerRahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Molecular Oncology|February 22, 2025
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancerMarina N Sharifi, Eric Feng, Nicholas R Rydzewski, et al.
Nature Genetics|July 17, 2024
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancerShuang G Zhao, Matthew Bootsma, Stanley Zhou, et al.
Pageof 3